Emmaus Life Sciences (Emmaus Life Sciences) Price-to-Operating-Cash-Flow : (As of May. 11, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Emmaus Life Sciences Price-to-Operating-Cash-Flow?

As of today (2024-05-11), Emmaus Life Sciences's share price is $0.105. Emmaus Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02. Hence, Emmaus Life Sciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Emmaus Life Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

EMMA's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.92
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Emmaus Life Sciences's Cash Flow from Operations per share for the three months ended in Sep. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 1.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 69.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 62.80% per year.

During the past 13 years, Emmaus Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 86.60% per year. The lowest was -654.90% per year. And the median was 17.00% per year.

Emmaus Life Sciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Emmaus Life Sciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emmaus Life Sciences Price-to-Operating-Cash-Flow Chart

Emmaus Life Sciences Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Emmaus Life Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Emmaus Life Sciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Emmaus Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emmaus Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Emmaus Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Emmaus Life Sciences's Price-to-Operating-Cash-Flow falls into.

Emmaus Life Sciences Price-to-Operating-Cash-Flow Calculation

Emmaus Life Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.105	/	-0.016
	=

Emmaus Life Sciences's Share Price of today is $0.105.
Emmaus Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Emmaus Life Sciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Emmaus Life Sciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmaus Life Sciences (Emmaus Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Emmaus Life Sciences Inc (OTCPK:EMMA) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

21250 Hawthorne Boulevard, Suite 800, Torrance, CA, USA, 90503

Website

https://www.emmausmedical.com

Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.

Executives

Seah H. Lim	director	21250 HAWTHORNE BLVD., SUITE 800, TORRANCE CA 90503
Willis C Lee	director, officer: Vice Chairman & COO	20725 S. WESTERN AVE., SUITE 136, TORRANCE CA 90501
Yutaka Niihara	director, 10 percent owner, officer: Chairman and CEO	20725 S. WESTERN BLVD., SUITE 136, TORRANCE CA 90501
Lori Teranishi	director	1000 BISHOP STREET, SUITE 500, HONOLULU HI 96813
Charles William Stark	officer: SVP, Clinical Development	21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE CA 90503
George Sekulich	officer: CIO & SVP	21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE CA 90503
Lui Alfred Fu Kong	director	21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE CA 90503
Jane Pine Wood	director	956 MAIN STREET, DENNIS MA 02638
Wei Peu Zen	director	21250 HAWTHORNE BLVD., SUITE 800, TORRANCE CA 90503
Sherwood Joseph Charles Iii	officer: Chief Financial Officer	21250 HAWTHORNE BLVD., SUITE 800, TORRANCE CA 90503
Masaharu Osato	director	3440 LOMITA BOULEVARD, SUITE 320, TORRANCE CA 90505
Ian Harvey Zwicker	director	21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE CA 90503
Lan T. Tran	officer: Chief Administrative Officer	20725 S. WESTERN AVE., SUITE 136, TORRANCE CA 90501
Robert Iv Dickey	director	320 WEST MERMAID LANE, PHILADELPHIA PA 19118
Yasushi Nagasaki	officer: Sr. VP Finance	20725 S. WESTERN AVE., SUITE 136, TORRANCE CA 90501